Moreover, the combination therapy robustly expelled YAP/TAZ outside the nucleus thereby impacting its association with TEAD transcription, illustrating the importance of agrin–EGFR feedback in potentiating nuclear YAP/TAZ in lung cancers. The gene discussed is AGRN; the disease is lung cancer.